China丨Yifan : registration of Prothioconazole approved from ICAMA

On Oct 10, 2022, ICAMA shown that Yifan got the registration approval of Prothioconazole with the registration NO. PD20220242, which will be valid until Oct 08, 2027.

Yifan is committed to expanding the global market of Prothioconazole. In the EU market, the Prothioconazole TC from Yifan has been recognized as equivalent by the EU earlier. In the Brazilian market, the registration of Yifan Source is currently under review and is expected to be approved in 2023.

In the future, Yifan will continue to take Prothioconazole as a strategic core product to build and make it face the global market. It is reported that the company will plan to carry out comprehensive registration in North America, South America and Asia Pacific markets in the future, to help foreign customers more quickly use the formulations of Prothioconazolet.